Furthermore, the presence of specific alterations seems to influence the course of disease in HNSCC as mutations in TP53, NOTCH1, and CDKN2A were associated with inferior survival outcomes and patients responding to cisplatin were more likely to harbor FAT1 mutations [90]. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.